Global Life Sciences Fund

By understanding the science and business of health care, the strategy invests in companies addressing unmet medical needs or improving health care efficiencies

ISIN
IE0009355771

NAV
USD 38.91
As of 27/05/2020

1-Day Change
(-)
As of 27/05/2020

Morningstar Rating

Overview

OBJECTIVE AND INVESTMENT POLICY

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.

Note: You should not make investment decisions based solely on marketing materials. You should read the Prospectus and the Product Highlights Sheet of the Fund for more details of the investment risks and seek independent professional advice where appropriate.

ABOUT THIS FUND

  • Looks to invest in companies addressing unmet medical needs or making the health care system more efficient
  • Aims to maintain a balanced portfolio across subsectors (pharmaceuticals, biotechnology, health care services, and medical devices)
  • An experienced team of specialists that seeks to understand the science and the business of health care

PORTFOLIO MANAGEMENT

Andy Acker, CFA

Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Performance

ANNUAL FEES & EXPENSES (As of Fiscal Year End, 31/12/2019)
Initial Charge 5.00%
Annual Charge 1.50%
Ongoing Charge
(As of 31/12/2019)
2.40%

Portfolio

Top Holdings (As of 30/04/2020)
% OF FUND
Merck & Co Inc 4.06
Novartis AG (ADR) 3.72
UnitedHealth Group Inc 3.52
AstraZeneca PLC 3.19
Roche Holding AG 2.98
Abbott Laboratories 2.95
Thermo Fisher Scientific Inc 2.82
Humana Inc 2.60
AbbVie Inc 2.53
Boston Scientific Corp 2.50
Total 30.87
Sector Allocation % OF FUND % OF FUND (As of 30/04/2020)
Health Care 97.20
Cash & Equivalents 2.80
Regional Allocations % OF FUND % OF FUND (As of April 30, 2020)
North America 76.54
Europe 18.56
Japan 2.10
Cash & Equivalents 2.80

Documents

TOP